Register entry
- Registered sites
- 0
- Active NDC listings
- 16
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1616 active NDC listings: 16 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 16.
| Dosage form | NDCs |
|---|---|
| injection, solution | 8 |
| injection, suspension | 5 |
| injection, powder, lyophilized, for solution | 2 |
| tablet | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| lilly france | 15 |
| lilly s.a. | 1 |
Catalogue
Marketed products
16| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Donanemab | injection, solution | 62381-9401DRUG FOR FURTHER PROCESSING |
| - | Dulaglutide | injection, solution | 62381-1433DRUG FOR FURTHER PROCESSING |
| - | Dulaglutide | injection, solution | 62381-1434DRUG FOR FURTHER PROCESSING |
| - | Insulin glargine | injection, solution | 62381-7661DRUG FOR FURTHER PROCESSING |
| - | Insulin human | injection, suspension | 62381-0319DRUG FOR FURTHER PROCESSING |
| - | Insulin human | injection, solution | 62381-0509DRUG FOR FURTHER PROCESSING |
| - | Insulin human | injection, suspension | 62381-0719DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, suspension | 62381-7393DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, suspension | 62381-7394DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, solution | 62381-7516DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, suspension | 62381-7525DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, solution | 62381-7662DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, solution | 62381-9516DRUG FOR FURTHER PROCESSING |
| - | Pemetrexed disodium | injection, powder, lyophilized, for solution | 62381-7623DRUG FOR FURTHER PROCESSING |
| - | Pemetrexed disodium | injection, powder, lyophilized, for solution | 62381-7640DRUG FOR FURTHER PROCESSING |
| - | Raloxifene hydrochloride | tablet | 71210-4184DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing insulin lispro
- Eli Lilly and Company10 sites · 189 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Lilly del Caribe, Inc.0 sites · 46 NDC
- Eli Lilly Italia SPA0 sites · 20 NDC
Enquiry
Common questions
- Is Lilly France FDA approved?
- Lilly France holds no registered establishment of its own; 16 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Lilly France make?
- 16 products are listed under Lilly France in the openFDA NDC Directory, most often as injection, solution; injection, suspension; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.